1. Home
  2. SLS vs DGHI Comparison

SLS vs DGHI Comparison

Compare SLS & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • DGHI
  • Stock Information
  • Founded
  • SLS 2012
  • DGHI 2017
  • Country
  • SLS United States
  • DGHI United States
  • Employees
  • SLS N/A
  • DGHI N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • DGHI Finance: Consumer Services
  • Sector
  • SLS Health Care
  • DGHI Finance
  • Exchange
  • SLS Nasdaq
  • DGHI Nasdaq
  • Market Cap
  • SLS 75.3M
  • DGHI 61.7M
  • IPO Year
  • SLS N/A
  • DGHI N/A
  • Fundamental
  • Price
  • SLS $0.90
  • DGHI $2.07
  • Analyst Decision
  • SLS
  • DGHI Strong Buy
  • Analyst Count
  • SLS 0
  • DGHI 1
  • Target Price
  • SLS N/A
  • DGHI $2.50
  • AVG Volume (30 Days)
  • SLS 1.6M
  • DGHI 263.9K
  • Earning Date
  • SLS 11-13-2024
  • DGHI 11-15-2024
  • Dividend Yield
  • SLS N/A
  • DGHI N/A
  • EPS Growth
  • SLS N/A
  • DGHI N/A
  • EPS
  • SLS N/A
  • DGHI N/A
  • Revenue
  • SLS N/A
  • DGHI $42,146,057.00
  • Revenue This Year
  • SLS N/A
  • DGHI N/A
  • Revenue Next Year
  • SLS N/A
  • DGHI N/A
  • P/E Ratio
  • SLS N/A
  • DGHI N/A
  • Revenue Growth
  • SLS N/A
  • DGHI 100.56
  • 52 Week Low
  • SLS $0.50
  • DGHI $0.84
  • 52 Week High
  • SLS $1.72
  • DGHI $2.54
  • Technical
  • Relative Strength Index (RSI)
  • SLS 30.01
  • DGHI 53.99
  • Support Level
  • SLS $0.86
  • DGHI $1.56
  • Resistance Level
  • SLS $0.98
  • DGHI $2.22
  • Average True Range (ATR)
  • SLS 0.11
  • DGHI 0.23
  • MACD
  • SLS -0.02
  • DGHI -0.02
  • Stochastic Oscillator
  • SLS 21.74
  • DGHI 60.61

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

Share on Social Networks: